Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01976299 · ClinicalTrials.gov registry record · NA
AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN
A NA study, sponsored by Osprey Medical.
- Completed
- Registry status
- NA
- Development phase
- 578
- Enrollment target
NCT01976299: Completed NA study, sponsored by Osprey Medical.
NCT01976299 is a NA study that has completed, run by Osprey Medical. The registered enrollment target is 578 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01976299, a NA study, has completed, sponsored by Osprey Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 578 participants
- Enrollment target
Study Summary
The Osprey Medical AVERT System is indicated to reduce contrast media (CM) exposure to the kidneys during percutaneous coronary procedures thereby reducing the risk of contrast induced nephropathy (CIN).
Primary Outcome
Reduction in the incidence of Contrast Induced Nephropathy (CIN) by evaluating Serum Creatinine levels in subjects for up to 5 days.
Interventions
- DEVICE AVERT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 578 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-09 |
| Phase | NA |
What the finished NCT01976299 record still lists
NCT01976299 is an interventional study that assigns participants to a tested intervention. The registered 578 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which AVERT is the first listed.
NCT01976299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01976299 about?
NCT01976299 is a clinical study titled "AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN". The Osprey Medical AVERT System is indicated to reduce contrast media (CM) exposure to the kidneys during percutaneous coronary procedures thereby reducing the risk of contrast induced nephropathy (CIN).
What is the current status of trial NCT01976299?
This trial is currently completed. It is a NA study. The enrollment target is 578 participants. The study started on 2013-12. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01976299?
The interventions under investigation include: AVERT (DEVICE).
Who is sponsoring clinical trial NCT01976299?
This trial is sponsored by Osprey Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01976299's enrollment target sits among peer trials
578 177th of 2000 higher than 1,824 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07290543 · 578 participants · NA
Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia